Director, Field Market Access

Company Overview:

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Position Overview:

The Director, Field Market Access will serve as the primary field market access leader within a defined geographic region. This role is responsible for engaging and negotiating with payers, partnering with Treatment Centers on billing and coding, and collaborating with key stakeholders to support patient access across the Beam portfolio.

This field-based position will execute market access strategies focused on payer engagement, reimbursement, contracting, affordability, and patient access. As a key member of the commercial organization, this individual will play a critical role in supporting coverage and ensuring appropriate patient access for Beam's first commercial product, risto-cel, an investigational ex vivo gene therapy being studied for the treatment of Sickle Cell Disease.

We are actively hiring for several positions across regions nationwide.

Responsibilities:

• Negotiate directly with Commercial and Government Payers to ensure pricing and coverage for the Beam portfolio, potentially including managed Medicaid and Medicaid FFS.
• Execute the Market Access Strategies for the Beam portfolio with Payers and Treatment Centers, including communicating economic value propositions.
• Educate providers on local payer trends, appropriate billing and coding for gene therapy, providing support to offices for individual patient reimbursement journeys, including troubleshooting reimbursement concerns.
• Monitor, analyze, and influence local payer trends in rare disease and gene therapy to ensure environment supports innovation in gene therapy affordability and accessibility.
• Provide training and education programs on reimbursement best practices and health policy issues to internal stakeholders and external stakeholders, such as Treatment Centers.
• Work seamlessly with cross functional field pod (Medical Affairs, Gene Therapy Operations, Key Account Management) to support access and coverage of Beam’s portfolio.
• Develop local / regional relationships with professional societies, medical associations, advocacy groups, thought leaders and trade groups for the purposes of driving comprehensive coverage and adequate payment.

Qualifications:

• Bachelor's degree required; advanced degree preferred.
• 10+ years of progressive experience in the pharmaceutical or biotech industry with 5+ years in market access, including field roles.
• Hospital and payer experience establishing coverage policies for complex therapies required.
• Demonstrated success in building and managing relationships with payers and financial decision-makers in Treatment Centers.
• Must have established relationships with payers (Commercial payers – required; Medicaid – preferred).
• Buy & bill experience required; Experience in cell or gene therapy preferred.
• Experience working in local, cross-functional field teams, including Key Account Managers, MSLs, and Patient Operations.
• Excellent communication, presentation, and negotiation skills.
• Proficiency with CRM systems, PowerPoint, and Excel.
• Willingness to travel approximately 50% of the time/as needed.

Beam’s field team operates through an account-based pod model (a team structure that groups cross-functional specialists together to manage a specific segment of accounts from lead to close). The Director, Key Account Manager (KAM), owns the integrated account strategy, account plan, and overall account performance. The Director, Field Market Access owns access, reimbursement and payer engagement. The Associate Director/Director, Gene Therapy Operations (GTO) owns site operational readiness and apheresis and patient logistics executions. Each role and team is expected to work cross functionally while maintaining clear functional accountability.

The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.